• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GH Research PLC - Ordinary Shares (NQ:GHRS)

    27.20 -0.55 (-2.00%)
    Streaming Delayed Price Updated: 10:57 AM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 89,660
    Open 27.78
    Bid (Size) 27.00 (100)
    Ask (Size) 27.39 (200)
    Prev. Close 27.75
    Today's Range 26.32 - 27.82
    52wk Range 11.32 - 31.00
    Shares Outstanding 52,020,849
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗
    Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline. 
    Via The Motley Fool
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    Via Chartmill

    Performance

    YTD
    +105.4%
    +105.4%
    1 Month
    -4.5%
    -4.5%
    3 Month
    +38.8%
    +38.8%
    6 Month
    +63.8%
    +63.8%
    1 Year
    +81.5%
    +81.5%

    More News

    Read More
    News headline image
    Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
    Via FinancialNewsMedia
    News headline image
    Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    GH Research Announces Publication of Phase 2a Postpartum Depression Results
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    These Analysts Revise Their Forecasts On GH Research After Q1 Results ↗
    Via Benzinga
    News headline image
    GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    GH Research Announces Pricing of $117.5 Million Underwritten Offering
    From GH Research PLC
    Via GlobeNewswire
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
    Via Finterra
    Topics Cannabis Initial Public Offering Intellectual Property
    News headline image
    GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    GH Research Reports Full Year 2025 Financial Results and Provides Business Update
    From GH Research PLC
    Via GlobeNewswire
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Why Is GHRS Stock Rising Today? ↗
    Via Stocktwits
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment ↗
    Via Stocktwits
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    GH Research to Announce IND Status for GH001
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    GH Research PLC (NASDAQ:GHRS) Reports Q3 2025 Earnings Beat and Clinical Progress ↗
    Via Chartmill
    Topics Earnings
    News headline image
    GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From GH Research PLC
    Via GlobeNewswire
    News headline image
    Depression-Focused GH Research Shares Could See Significant Upside: Analyst ↗
    Via Benzinga
    News headline image
    This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
    From GH Research PLC
    Via GlobeNewswire

    Frequently Asked Questions

    Is GH Research PLC - Ordinary Shares publicly traded?
    Yes, GH Research PLC - Ordinary Shares is publicly traded.
    What exchange does GH Research PLC - Ordinary Shares trade on?
    GH Research PLC - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for GH Research PLC - Ordinary Shares?
    The ticker symbol for GH Research PLC - Ordinary Shares is GHRS on the Nasdaq Stock Market
    What is the current price of GH Research PLC - Ordinary Shares?
    The current price of GH Research PLC - Ordinary Shares is 27.20
    When was GH Research PLC - Ordinary Shares last traded?
    The last trade of GH Research PLC - Ordinary Shares was at 07/28/26 10:57 AM ET
    What is the market capitalization of GH Research PLC - Ordinary Shares?
    The market capitalization of GH Research PLC - Ordinary Shares is 1.41B
    How many shares of GH Research PLC - Ordinary Shares are outstanding?
    GH Research PLC - Ordinary Shares has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.